Surfactant protein A (SP-A)-mediated bacterial clearance: SP-A and cystic fibrosis

Am J Respir Cell Mol Biol. 2001 Dec;25(6):668-72. doi: 10.1165/ajrcmb.25.6.f221.
No abstract available

Publication types

  • Comment

MeSH terms

  • Bacteria / metabolism*
  • Bacterial Adhesion / drug effects
  • Bacterial Adhesion / physiology
  • Bacterial Infections / complications
  • Bacterial Infections / immunology
  • Bacterial Infections / metabolism*
  • Cell Line
  • Chemotactic Factors / pharmacology
  • Chemotaxis / drug effects
  • Chemotaxis / physiology
  • Cystic Fibrosis / complications
  • Cystic Fibrosis / immunology
  • Cystic Fibrosis / metabolism*
  • Disease Susceptibility
  • Free Radicals
  • Glycoproteins / pharmacology
  • Glycoproteins / physiology
  • Ligands
  • Lung / microbiology*
  • Macrophage Activation / drug effects
  • Macrophages, Alveolar / drug effects
  • Macrophages, Alveolar / physiology*
  • Monocytes / immunology
  • Monocytes / metabolism
  • Organ Specificity
  • Phagocytosis / drug effects
  • Phagocytosis / physiology*
  • Pneumonia, Bacterial / etiology
  • Pneumonia, Bacterial / immunology
  • Pneumonia, Bacterial / metabolism
  • Proteolipids / pharmacology
  • Proteolipids / physiology*
  • Pseudomonas aeruginosa / metabolism
  • Pulmonary Surfactant-Associated Protein A
  • Pulmonary Surfactant-Associated Protein D
  • Pulmonary Surfactant-Associated Proteins
  • Pulmonary Surfactants / pharmacology
  • Pulmonary Surfactants / physiology*

Substances

  • Chemotactic Factors
  • Free Radicals
  • Glycoproteins
  • Ligands
  • Proteolipids
  • Pulmonary Surfactant-Associated Protein A
  • Pulmonary Surfactant-Associated Protein D
  • Pulmonary Surfactant-Associated Proteins
  • Pulmonary Surfactants